DI BONAVENTURA, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 10.725
EU - Europa 7.817
AS - Asia 6.888
SA - Sud America 714
AF - Africa 107
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 12
Totale 26.277
Nazione #
US - Stati Uniti d'America 10.526
SG - Singapore 2.762
CN - Cina 1.976
RU - Federazione Russa 1.450
IT - Italia 1.311
IE - Irlanda 998
UA - Ucraina 995
GB - Regno Unito 872
SE - Svezia 722
TR - Turchia 713
BR - Brasile 565
VN - Vietnam 559
FR - Francia 494
DE - Germania 459
IN - India 321
FI - Finlandia 213
HK - Hong Kong 132
CA - Canada 104
BD - Bangladesh 80
MX - Messico 67
JP - Giappone 62
IQ - Iraq 57
AR - Argentina 55
ES - Italia 53
PL - Polonia 48
NL - Olanda 42
AT - Austria 38
ZA - Sudafrica 37
KR - Corea 31
CZ - Repubblica Ceca 23
EC - Ecuador 23
CH - Svizzera 22
VE - Venezuela 21
BE - Belgio 19
PK - Pakistan 19
SA - Arabia Saudita 19
MA - Marocco 18
ID - Indonesia 17
CO - Colombia 15
LT - Lituania 15
MY - Malesia 15
IL - Israele 14
LB - Libano 13
PH - Filippine 12
UZ - Uzbekistan 12
EG - Egitto 11
EU - Europa 11
IR - Iran 11
KE - Kenya 11
CL - Cile 10
JO - Giordania 10
TH - Thailandia 10
PY - Paraguay 9
AE - Emirati Arabi Uniti 8
TN - Tunisia 8
AU - Australia 7
PE - Perù 7
GR - Grecia 6
JM - Giamaica 6
NP - Nepal 6
RS - Serbia 6
UY - Uruguay 6
CR - Costa Rica 5
OM - Oman 5
AZ - Azerbaigian 4
BY - Bielorussia 4
DK - Danimarca 4
DZ - Algeria 4
PT - Portogallo 4
RO - Romania 4
SN - Senegal 4
SY - Repubblica araba siriana 4
AL - Albania 3
AO - Angola 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
PA - Panama 3
TW - Taiwan 3
BG - Bulgaria 2
BH - Bahrain 2
ET - Etiopia 2
GE - Georgia 2
HN - Honduras 2
NG - Nigeria 2
NI - Nicaragua 2
SV - El Salvador 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BO - Bolivia 1
BZ - Belize 1
CG - Congo 1
EE - Estonia 1
GD - Grenada 1
GY - Guiana 1
HR - Croazia 1
Totale 26.257
Città #
Singapore 1.974
Chandler 1.323
San Jose 1.287
Jacksonville 1.199
Dublin 993
Ashburn 655
Dearborn 642
Southend 574
Dallas 545
Beijing 500
Princeton 475
Izmir 376
Nanjing 344
Los Angeles 232
Chieti 200
Santa Clara 190
Wilmington 184
Cambridge 182
Council Bluffs 179
Ho Chi Minh City 177
Tongling 151
The Dalles 132
New York 126
Nanchang 125
Altamura 120
Buffalo 118
Hong Kong 118
Ann Arbor 113
Moscow 113
Hanoi 112
Boardman 90
Munich 87
Rome 77
Kunming 71
Orem 65
São Paulo 65
Pescara 63
Shenyang 60
Hebei 59
Redondo Beach 58
Dong Ket 49
Tokyo 47
Jiaxing 45
Washington 42
Woodbridge 41
Milan 40
Tianjin 40
Chennai 38
Chicago 37
Hefei 37
Warsaw 37
Brooklyn 36
Norwalk 36
Montreal 34
Vienna 32
Boston 30
Houston 30
Da Nang 29
Frankfurt am Main 29
Stockholm 29
Changsha 28
Toronto 28
Amsterdam 27
Nuremberg 27
Atlanta 26
Phoenix 25
Pune 24
Hangzhou 23
Johannesburg 22
Poplar 22
Mumbai 21
Seattle 21
Seoul 21
Augusta 20
Baghdad 20
Civitanova Marche 20
Denver 20
Grevenbroich 20
Jinan 20
Mexico City 20
Haiphong 19
San Francisco 19
San Mateo 19
Brussels 18
London 18
Memphis 18
Guangzhou 17
Orange 17
Zhengzhou 17
Ankara 16
Düsseldorf 16
Rio de Janeiro 16
Ancona 15
Dhaka 15
Helsinki 15
Turku 15
Brno 14
Kocaeli 14
Manchester 14
Palermo 14
Totale 15.673
Nome #
Adhesion and biofilm formation by Staphylococcus aureus clinical isolates under conditions relevant to the host: Relationship with macrolide resistance and clonal lineages 804
Identification, antimicrobial resistance and molecular characterization of the human emerging pathogen Streptococcus gallolyticus subsp. pasteurianus 222
Addition of teicoplanin or vancomycin for the treatment of documented bacteremia due to gram-positive cocci in neutropenic patients with hematological malignancies: Microbiological, clinical and economic evaluation 204
Streptococcus dysgalactiae subsp. equisimilis: two cases of tonsillitis. 187
Effetto post-antibiotico di levofloxacina e grepafloxacina nei confronti di Stenotrophomonas maltophilia. 186
Attività battericida ed anti-biofilm di peptidi antimicrobici verso patogeni multi-resistenti isolati da pazienti con fibrosi cistica. 185
Efficacy of phages and antibiotic-phage combinations against biofilm by Pseudomonas aeruginosa from cystic fibrosis patients 172
Absence of Helicobacter pylori in tonsillar swabs from dyspeptic patients. 170
Unusual oropharyngeal asymptomatic manifestations caused by atypical pathogens detected by PCR into altered ecosystems of an infertile couple. 170
Fatal sepsis by Klebsiella pneumoniae in a patient with systemic lupus erythematosus: the importance of postmortem microbiological examination for the ex post diagnosis of infection. 167
Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm 162
An overview on streptococcus bovis/streptococcus equinus complex isolates: Identification to the species/subspecies level and antibiotic resistance 162
Colonic adenoma-associated Escherichia coli express specific phenotypes 158
Antibiotic resistance and biofilm in Stenotrophomonas maltophilia isolates from cystic fibrosis and non-cystic fibrosis patients 155
Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients. 154
Phylogenetic relationships, biofilm formation, motility, antibiotic resistance and extended virulence genotypes among Escherichia coli strains from women with community-onset primitive acute pyelonephritis 152
Analisi proteomica del biofilm formato da un ceppo di Stenotrophomonas maltophilia isolato da fibrosi cistica. 149
A novel biotechnology product for the degradation of biofilm-associated polysaccharides produced by Streptococcus mutans 148
Optimal combination of media for primary isolation of Helicobacter pylori from gastric biopsy specimens. 146
A new challenge in cystic fibrosis antimicrobial therapy: activity of electrochemically synthesized silver nanoparticles against planktonic and biofilm cells of bacterial pathogens 145
In vitro microbiology studies on a new peritoneal dialysis connector 143
Accuracy of flagella’s staining in the diagnosis of Helicobacter pylori infection: comparative study with the hystology, culture, and rapid urease test. 143
A European perspective on intravascular catheter-related infections: report on the microbiology workload, aetiology and antimicrobial susceptibility (ESGNI-005 Study). 143
Detection of Helicobacter pylori by PCR on gastric biopsy specimens taken for CP test: comparison with histopathological analysis. 141
Peptide dendrimers as “lead compounds” for the treatment of chronic lung infections by Pseudomonas aeruginosa in cystic fibrosis patients: In vitro and in vivo studies 141
First report of an acute purulent maxillary sinusitis caused by Pseudomonas aeruginosa secondary to dental implant placement in an immunocompetent patient. 137
An overview of various typing methods for clinical epidemiology of the emerging pathogen Stenotrophomonas maltophilia. 136
Biofilm formation by Stenotrophomonas maltophilia: modulation by quinolones, trimethoprim-sulfamethoxazole, and ceftazidime. 135
Monitoraggio microbiologico di aria e superfici in ambiente di prime cure chirurgiche di ambulatorio INAIL. 135
Comparison of Etest, agar dilution, broth microdilution and disk diffusion methods for testing in vitro activity of levofloxacin against Staphylococcus spp. isolated from neutropenic cancer patients 134
Accuratezza di Etest per lo studio di attività in vitro di combinazioni tra fluorochinoloni e cefalosporine di terza generazione verso Pseudomonas aeruginosa. 134
Meticillin-heteroresistant Staphylococcus pasteuri from an apheresis platelet product 133
Effect of levofloxacin on Stenotrophomonas maltophilia biofilm and its relationship with SmeDEF multidrug efflux pump expression under conditions relevant to the cystic fibrosis lung 133
Characterization of biofilm formation by Myroides odoratimimus isolated from post-traumatic calcaneal recurrent ulcer in diabetic patient 133
Aumentati livelli mucosali gastrici di IL-1alfa, IL-6 ed IL-8 in pazienti Helicobacter pylori-positivi affetti da cardiopatia ischemica. 132
Alterazione dei livelli tessutali di ioni metallici in un modello murino di infezione polmonare da Stenotrophomonas maltophilia. 132
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 132
Role of excessive inflammatory response to Stenotrophomonas maltophilia lung infection in DBA/2 mice and implications for cystic fibrosis. 132
Accuratezza di E test nella determinazione in vitro della sensibilità di stafilococchi isolati da pazienti neutropenici verso levofloxacina. 129
Evaluation of antibacterial and antibiofilm mechanisms by usnic acid against methicillin-resistant Staphylococcus aureus 129
Accuratezza di E test per il monitoraggio dell’antibiotico-sensibilità di Pseudomonas aeruginosa isolati da pazienti sottoposti a cateterismo vescicale. 128
Microbial cooperation in cystic fibrosis: Stenotrophomonas maltophilia significantly modulates Pseudomonas aeruginosa virulence. 128
Identification, antimicrobial resistance and molecular characterization of the human emerging pathogen Streptococcus gallolyticus subsp pasteurianus 128
Sensibilità in vitro ai fluorichinoloni di Stenotrophomonas maltophilia isolati da pazienti neutropenici. 127
Comparative in vitro activity of levofloxacin and ciprofloxacin against bacterial isolates from neutropenic patients. 126
Two cases of vaginitis caused by itraconazole-resistant saccharomyces cerevisiae and a review of recently published studies. 126
Ulcer infection by ESbetaL-producing Proteus mirabilis: a case report. 126
Ricerca di Helicobacter pylori tramite PCR su biopsie gastriche sottoposte al test rapido all’ureasi (CP-test). 126
Helicobacter pylori Outer Membrane Vesicles (OMVs) as DNA shuttles and structural components of biofilm EPS 126
Development of a nanocomposite membrane based on reduced graphene (r-GO) and zeolite 13X for the removal of metal ions with bactericidal actions 126
null 125
Comparison of the E test to agar dilution and broth microdilution methods for quantitative antimicrobial susceptibility testing of Helicobacter pylori. 124
Ottimale sopravvivenza di Actinobacillus actinomycetemcomitans sotto varie condizioni di trasporto. 124
Isolamento di Actinobacillus actinomycetemcomitans nella placca sottogengivale di pazienti portatori di apparecchiature ortodontiche 124
Anaerobiosi ed ambiente acido influenzano l’attività in vitro di colistina nei confronti del biofilm formato da ceppi di Pseudomonas aeruginosa isolati da pazienti affetti da fibrosi cistica. 124
New insights in Staphylococcus pseudintermedius pathogenicity: antibiotic-resistant biofilm formed by a human wound-associated strain. 124
Giving Drugs a Second Chance: Antibacterial and Antibiofilm Effects of Ciclopirox and Ribavirin against Cystic Fibrosis Pseudomonas aeruginosa Strains 124
Biofilm microbici come sistema dinamico in risposta allo stress ambientale. Approcci innovativi nella prevenzione e formulazione di nuove strategie terapeutiche integrate 123
Normal breathing releases SARS-CoV-2 into the air 123
A case ofpharyngitis caused by Streptococcus pneumoniae. 122
Management and triage of women in follow-up for low-grade cervical disease: association of DNA and RNA-Based methods 121
Effect of environmental factors on biofilm formation by clinical Stenotrophomonas maltophilia strains. 121
Bacteriostatic and bactericidal in vitro activities of clarithromycin and erythromycin against periodontopathic Actinobacillus actinomycetemcomitans. 121
Misidentification of ampicillin-sulbactam heteroresistance in Acinetobacter baumannii strains from ICU patients 120
In vitro activity of clarithromycin against intracellular Helicobacter pylori. 120
Antibiotico-resistenza di gram-negativi isolati in Terapia Intensiva nel triennio 1996-1998. 120
Evaluation of the E Test for Antimicrobial Susceptibility Testing of Pseudomonas aeruginosa Isolates from Patients with Long-Term Bladder Catheterization 119
Pan-azole-resistant Candida guilliermondii from a leukemia patient's silent funguria 119
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 119
Usefulness of Leifson staining method in diagnosis of Helicobacter pylori infection. 119
Staphylococcus pasteuri bacteraemia in a patient with leukaemia. 118
Attività in vitro di levofloxacina verso isolati clinici da pazienti neutropenici. 118
Nuovi sistemi emocolturali automatici, ESP 128 (Difco) e Bact/Alert (Organon Teknika): analisi comparativa. 118
Frequency of detection of Actinobacillus actinomycetemcomitans in young patients during fixed orthodontic therapy. 117
Attività in vitro di roxitromicina in confronto con eritromicina verso Actinobacillus actinomycetemcomitans. 117
Effetto di concentrazioni sub-inibenti di moxifloxacina su Stenotrophomonas maltophilia isolati da fibrosi cistica 116
P Role of the antibiotic sensitivity test before helicobacter pylori eradication treatments in naive patients 116
Exposure to extremely low-frequency magnetic field affects biofilm formation by cystic fibrosis pathogens 116
Evolution of Stenotrophomonas maltophilia in Cystic Fibrosis Lung over Chronic Infection: A Genomic and Phenotypic Population Study 116
In Vitro Viability of External Eye Microbial Flora in Hydroxy-Propyl-Methylcellulose 115
Serum and mucosal cytokine profiles in patients with active Helicobacter pylori and ischemic heart disease: is their a relationship ? 115
Determination of ciprofloxacin and levofloxacin in human sputum collected from cystic fibrosis patients using microextraction by packed sorbent-high performance liquid chromatography photodiode array detector 115
Methicillin-resistant Staphylococcus pseudintermedius infection in a bone marrow transplant recipient 115
Microbiological Laboratory Diagnosis of Human Brucellosis: An Overview 115
Cell surface hydrophobicity, motility, and biofilm formation of Stenotrophomonas maltophilia clinical isolates. 114
In vitro bactericidal and antibiofilm activity of six antimicrobial peptides against multidrug-resistant pathogens from patients with cystic fibrosis. 114
Caratterizzazione fenotipica e genotipica della formazione di biofilm da parte di Stenotrophomonas maltophilia isolati da pazienti con fibrosi cistica. 114
Effetti dell’antibiotico-resistenza di H. pylori sulle terapie eradicanti. 114
Hafnia alvei from the farm to the delivery room 114
Identificazione di ceppi di Acinetobacter baumannii appartenenti a cloni epidemici mediante sequenziamento di geni coinvolti nella produzione di biofilm. 113
Produzione di biofilm in ceppi di Listeria monocytogenes isolati da matrice ittica: correlation con motilità ed idrofobicità cellulare. 113
Risk of misidentification of Enterobacter aerogenes inducible cephalosporinases. 113
Contribution of the Leifson stain to the detection of Helicobacter pylori from antral biopsy specimens. 113
Discrepancies between E-test and agar dilution methods for testing metronidazole susceptibility of Helicobacter pylori (T. Alarcon, D. Domingo, M. Lopez-Brea). Author’s Reply. 113
Stenotrophomonas maltophilia virulence and specific variations in trace elements during acute lung infection: implications in cystic fibrosis. 113
Spiral and coccoid forms of H. pylori in gastric mucosa biopsies: an electron microscopy study. 113
Virulence factors of Stenotrophomonas maltophilia, an emergent pathogen associated to cystic fibrosis. 112
In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies. 112
An antimicrobial bicyclic peptide from chemical space against multidrug resistant Gram-negative bacteria 112
In vivo bacterial cooperation in cystic fibrosis: exposure to Stenotrophomonas maltophilia affects Pseudomonas aeruginosa virulence in murine model of acute lung infection. 112
Totale 13.844
Categoria #
all - tutte 103.615
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.615


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021107 0 0 0 0 0 0 0 0 0 0 0 107
2021/20221.270 40 47 34 218 107 22 43 111 122 40 143 343
2022/20233.433 288 423 215 416 341 652 203 261 441 42 99 52
2023/20241.468 122 75 90 46 116 381 368 71 16 48 10 125
2024/20253.743 248 614 464 115 88 146 136 159 472 184 441 676
2025/20268.702 590 344 874 885 848 429 1.518 619 1.417 688 424 66
Totale 27.263